Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Cytek Biosciences, Inc. (CTKB) had Operating Cash Flow per Share of $0.19 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$200.45M |
|
$-6.02M |
|
$89.35M |
|
$111.11M |
|
$220.98M |
|
$-20.52M |
|
$14.82M |
|
$-5.70M |
|
$-5.70M |
|
$-6.02M |
|
$-6.02M |
|
$-6.02M |
|
$-6.02M |
|
$-20.52M |
|
$-10.03M |
|
130.61M |
|
130.61M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$396.45M |
|
$17.96M |
|
$103.05M |
|
$499.50M |
|
$67.66M |
|
$1.05M |
|
$36.10M |
|
$103.76M |
|
$395.74M |
|
$358.95M |
|
$395.74M |
|
129.21M |
|
| Cash Flow Statement Financials | |
$25.38M |
|
$-82.97M |
|
$-15.82M |
|
$167.63M |
|
$98.75M |
|
$-68.89M |
|
$26.85M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.86 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
55.43% |
|
-10.24% |
|
-10.24% |
|
-5.01% |
|
-2.84% |
|
-3.00% |
|
$22.14M |
|
-- |
|
-- |
|
-- |
|
0.40 |
|
2.04 |
|
3.31 |
|
110.32 |
|
-1.52% |
|
-1.68% |
|
-1.21% |
|
-1.52% |
|
$3.06 |
|
$0.17 |
|
|
Operating Cash Flow per Share |
$0.19 |